Apoptosis of human pancreatic carcinoma PC-2 cells by an antisense oligonucleotide specific to point mutated K-ras

Pathology and Oncology Research

Volumn 20, Issue 1, 2014, Pages 81-85

  Yongxiang, Wang ^a   Liang, Gao ^a   Qinshu, Shao ^a  

^a ZHEJIANG PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

Antisense oligonucleotide; K ras gene; Pancreatic carcinoma; Target gene

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER PROGNOSIS; CARCINOMA CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECT; DRUG SPECIFICITY; FLOW CYTOMETRY; G1 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; LIPOSOMAL GENE DELIVERY SYSTEM; NICK END LABELING; ONCOGENE K RAS; PANCREAS CARCINOMA; PHASE CONTRAST MICROSCOPY; POINT MUTATION; S PHASE CELL CYCLE CHECKPOINT;

APOPTOSIS; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; G1 PHASE; GENES, RAS; GENETIC THERAPY; HUMANS; IN SITU NICK-END LABELING; OLIGONUCLEOTIDES, ANTISENSE; PANCREATIC NEOPLASMS; POINT MUTATION; TRANSFECTION;

EID: 84896057573     PISSN: 12194956     EISSN: 15322807     Source Type: Journal    
DOI: 10.1007/s12253-013-9661-x     Document Type: Article

References (23)

1. Zongzheng J, Yongxiang W, Xi C, Tao W (2003) Peripancreatic artery ligation and artery infusion chemotherapy for advanced pancreatic carcinoma. Chin Med J 116:89-92
2. Luttges J, Hahn S, Kloppel G (2004) Where and when does pancreatic carcinoma start? Med Klin (Munich) 99:191-195 (Pubitemid 38560081)
3. Shuanzeng W, Tonghua L, Hongrui L, Jie G (2003) Unique GGT → GTT mutation at K-ras codon 12 in six human pancreatic cancer cell lines from Chinese patients. Chin Med J 116:1585-1587
4. Luttges J, Stigge C, Pacena M, Kloppel G (2004) Rare ductal adenocarcinoma of the pancreas in patients younger than age 40 years. Cancer 100:173-182
5. Wei S, Liang Z, Gao J,Wu S, Liu H, Liu T (2005) Patterns of K-ras codon 12 and 13 mutations found in pancreatic adenocarcinoma of 30 Chinese patients by microdissection, PCR and direct sequencing. J Gastroenterol Hepatol 20:67-72 (Pubitemid 40143636)
6. Matsubayashi H, Watanabe H, Ajioka Y, Nishikura K, Yamano M, Seki T et al (2000) Different amounts of K-ras mutant epithelial cells in pancreatic carcinoma and mass-forming pancreatitis. Pancreas 21:77-85 (Pubitemid 30421938)
7. Kita K, Saito S, Morioka CY,Watanabe A (1999) Growth inhibition on human pancreatic cancer cell lines by anti-sense oligonucleotides specific to mutated K-ras genes. Int J Cancer 80:553-558 (Pubitemid 29047520)
8. Higgins KA, Peres JR, Coleman TA, Dorshkind K, McComas WA, Sarmiento UM et al (1993) Anti-sense inhibition of the p65 submit of NF-k B block tumorigenecity and causes tumor regression. Proc Nat Acad Sci 90:9901-9905 (Pubitemid 23328218)
9. Tonghua L, Zhiyong W, Lei Z (1997) The inhibitary effect of modified Antisense oligonucleotide on the growth of pancreatic carcinoma cell and the expression of target gene. Chin J Patho 26:147-151
10. Hoffmann B, Lieberman DA (1994) Molecular regulation of apoptosis: differentiation/growth arrest primary response genes, protooncogenes, and tumor suppressor genes as positive and negative modulation. Oncogene 9:1807-1812
11. Jaattela M (1999) Escaping cell death: survival proteins in cancer. Exp Cell Res 248:30-43
12. Arya J, Finlayson CA, Shames BD et al (2000) Stimulated apoptosis as an antineoplastic strategy. Surgery 127:366-369
13. Humenil D, Neel H, Lacout C et al (1994) Infection with a Kirsten-retrovirus can induce a multiplicity of tumorigenic phenotypes in the interleukin-3-dependent FDC-P1 cells. Exp Hematol 22:178-185 (Pubitemid 24118539)
14. Kinoshita T, Yokota T, Aria KI et al (1995) Regulation of bcl-2 expression by oncogene ras protein in hematopoietic cells. Oncogene 10:2207-2212
15. Arends MJ, McGregor AH, Wyllie AH (1994) Apoptosis is inversely related to necrosis and determines net growth in tumors bearing constitutively expressed myc, ras, and HPVoncogenes. Am J Pathol 144:1045-1052
16. Yong-xiang W, Liang G, Zong-zheng J (2007) Inhibitary effects of antisense oligonucleotide specific to K-ras point mutation on the target gene expression in human pancreatic carcinoma cells. Chin Med J 120:1448-1450
17. Ward RL, Todd AV, Santiago F et al (1997) Activation of the K-ras in colorectal neoplasms is associated with decreased apoptosis. Cancer 70:1106-1113 (Pubitemid 27118207)
18. Peli J, Schroter M, Rudaz C et al (1999) Oncogenic Ras inhibits Fas ligand-mediated apoptosis by downregulating the expression of Fas. EMBO J 18:1824-1831 (Pubitemid 29158526)
19. Potten CS, Li YQ, O'Connor PL et al (1992) A possible explanation for the differential cancer incidence in the intestine, based on distribution of the cytotoxic effects of carcinogens in the murine large bowel. Carcinogenesis 3:2305-2312 (Pubitemid 23022973)
20. Mizukami Y, Ura H, Obara T et al (2001) Requirement of cjun N-terminal kinase for apoptotic cell death induced by farnesyltransferase inhibitor, farnesylamine, in human pancreatic cancer cells. Biochem Biophys Res Commun 288(1):198-204 (Pubitemid 32999746)
21. Fenton RG, Hixon JA, Wright PW et al (1998) Inhibition of Fas (CD95) expression and fas-mediated apoptosis by oncogenic ras. Cancer Res 58:3391-3400 (Pubitemid 28371081)
22. Fushida S, Nishimura GI, Shimizu K et al (2001) Human pancreatic cancer cells disable function of fas receptors at several levels in fas signal transduction pathway. Int J Oncol 18:311-316
23. Gulbins E, Bissonnette R, Mahboubi A et al (1995) Fas induced apoptosis is mediated via a cermide-initiated RAS signaling pathway. Immunity 2:341-351